MIV Therapeutics, Inc. (OTCBB: MIVT) (FRANKFURT: MIV), a leading developer of next-generation coatings and advanced drug delivery systems for cardiovascular stents and other implantable medical devices, today announced that Dr. Mark Landy, president of MIV Therapeutics, will present a company overview at the BMO Capital Markets Focus On Healthcare Conference on December 4, 2007 at 2:30 p.m. Eastern Time. The conference will be held at Millennium Broadway Hotel in New York City on December 4th and 5th.
